InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
17
T+90 hit rate
0%
T+90 mean return
-24.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Hamilton James C, Chief Medical Officer. Officer active across 1 company, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 20 reports have been published. Split: 0 buy · 17 sells. Total volume traded: €5.9m. Activity tracked since 1 January 2022. The latest transaction was disclosed on 23 April 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations20 total
10,000 shares@ US$75.000.0058% mcap15.6% of flowCommon StockSEC:0001830755-26-000007
10,000 shares@ US$75.000.0059% mcap15.6% of flowCommon StockSEC:0001830755-26-000007:0
4,625 shares@ US$61.240.0022% mcap5.9% of flowCommon StockSEC:0001830755-26-000002:0
4,625 shares@ US$61.245.9% of flowCommon StockSEC:0001830755-26-000002
20,000 shares@ US$35.000.0055% mcap14.5% of flowCommon StockSEC:0001830755-25-000011:0
20,000 shares@ US$35.0014.5% of flowCommon StockSEC:0001830755-25-000011
15,000 shares@ US$30.006.5% of flowCommon StockSEC:0001830755-25-000009:0
100,000 shares0Common StockSEC:0001628280-25-000807:0
▼
21,758 shares@ US$19.687.0% of flowCommon StockSEC:0001628280-25-000807:1
▼
10,971 shares@ US$20.113.6% of flowCommon StockSEC:0001628280-25-000807:2
▼
6,000 shares@ US$28.032.6% of flowCommon StockSEC:0001628280-24-014735:0
▼
4,238 shares@ US$36.472.4% of flowCommon StockSEC:0001628280-24-001576:0
3,500 shares@ US$31.811.7% of flowCommon StockSEC:0001628280-24-000748:0
3,000 shares@ US$35.531.7% of flowCommon StockSEC:0001628280-23-024351:0
7,230 shares@ US$37.404.3% of flowCommon StockSEC:0001209191-23-002479:0
1,194 shares@ US$37.460.7% of flowCommon StockSEC:0001209191-23-002110:0
9,955 shares@ US$64.890.0053% mcap13.9% of flowCommon StockSEC:0001209191-22-002284:0
9,955 shares@ US$64.890.0053% mcap27.9% of flowCommon StockSEC:0001209191-22-002284
55,000 shares0Common StockSEC:0001209191-22-001313:0
55,000 shares0Common StockSEC:0001209191-22-001313
20 of 20 declarations
About Hamilton James C
James C. Hamilton is the Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. He oversees clinical activities and drug development strategies. His role is essential in ensuring that the products developed meet safety and efficacy standards while contributing to innovation in the pharmaceutical field.
